Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

por Fragoulis, George E, Karamanakos, Anastasios, Arida, Aikaterini, Bournia, Vasiliki-Kalliopi, Evangelatos, Gerasimos, Fanouriakis, Antonis, Fragiadaki, Kalliopi, Kravvariti, Evrydiki, Laskari, Katerina, Panopoulos, Stylianos, Papazoglou, Nikolaos, Pappa, Maria, Tektonidou, Maria G, Sfikakis, Petros P
Publicado 2022

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

por Sidler, Daniel, Born, Alexander, Schietzel, Simeon, Horn, Michael P, Aeberli, Daniel, Amsler, Jennifer, Möller, Burkhard, Njue, Linet M, Medri, Cesare, Angelillo-Scherrer, Anne, Borradori, Luca, Seyed Jafari, S. Morteza, Radonjic-Hoesli, Susanne, Chan, Andrew, Hoepner, Robert, Bacher, Ulrike, Mani, Laila-Yasmin, Iype, Joseena Mariam, Suter-Riniker, Franziska, Staehelin, Cornelia, Nagler, Michael, Hirzel, Cedric, Maurer, Britta, Moor, Matthias B
Publicado 2022

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

por Boekel, Laura, Hooijberg, Femke, Vogelzang, Erik H, Besten, Yaëlle R, Leeuw, Maureen, Atiqi, Sadaf, van Vollenhoven, Ronald F, Wijbrandts, Carla A, Gerritsen, Martijn, Krieckaert, C, Dijkshoorn, Bas, Bakhlakh, Siham, Crooijmans, Juliette J, Voskuyl, Alexandre, van der Horst-Bruinsma, Irene E, Lems, Willem, Kuijpers, Taco W, van Ham, S Marieke, Wieske, Luuk, Eftimov, Filip, Kummer, Laura Y, van Dam, PJ Koos, Stalman, Eileen W, Steenhuis, Maurice, Keijzer, Sofie, Cristianawati, Olvi, Keijser, Jim, Loeff, Floris C, Tas, Sander W, Nurmohamed, Michael T, Boers, Maarten, Rispens, Theo, Wolbink, Gertjan
Publicado 2022

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

por Liew, Jean, Gianfrancesco, Milena, Harrison, Carly, Izadi, Zara, Rush, Stephanie, Lawson-Tovey, Saskia, Jacobsohn, Lindsay, Ja, Clairissa, Hyrich, Kimme L, Gossec, Laure, Strangfeld, Anja, Carmona, Loreto, Schäfer, Martin, Frãzao-Mateus, Elsa, Bulina, Inita, Stafford, Frances, Tufan, Abdurrahman, Graver, Christine, Yardımcı, Gözde Kübra, Zepa, Julija, Al Emadi, Samar, Cook, Claire, Abutiban, Fatemah, Dey, Dfiza, Katigbak, Genevieve, Kaufman, Lauren, Kowalski, Emily, Martínez-Martínez, Marco Ulises, Patel, Naomi J, Reyes-Cordero, Greta, Salido, Evelyn, Smith, Ellison, Snow, David, Sparks, Jeffrey, Wise, Leanna, Bhana, Suleman, Gore-Massy, Monique, Grainger, Rebecca, Hausmann, Jonathan, Sirotich, Emily, Sufka, Paul, Wallace, Zachary, Machado, Pedro M, Robinson, Philip C, Yazdany, Jinoos
Publicado 2022

Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors

por Venerito, Vincenzo, Stefanizzi, Pasquale, Fornaro, Marco, Cacciapaglia, Fabio, Tafuri, Silvio, Perniola, Simone, Iannone, Florenzo, Lopalco, Giuseppe
Publicado 2022

Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases

por Sieiro Santos, Cristiana, Calleja Antolin, Sara, Moriano Morales, Clara, Garcia Herrero, Juan, Diez Alvarez, Elvira, Ramos Ortega, Fernando, Ruiz de Morales, Jose G
Publicado 2022

Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disea...

por Laster, Andrew J, Lam, Gordon K, Gladue, Heather S, Kashif, Ahmad A, Siceloff, Erin P, Lackey, Virginia D, Robertson, Cheryl R, Toci, Ashley L, Calabrese, Leonard H
Publicado 2022

Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)

por Tran, Ai Phuong, Tassone, Daniel, Nossent, Johannes, Ding, Nik Sheng
Publicado 2022

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

por Bitoun, Samuel, Avouac, Jérôme, Henry, Julien, Ghossan, Roba, Al Tabaa, Omar, Belkhir, Rakiba, Nocturne, Gaetane, Mariaggi, Alice Andrée, Rozenberg, Flore, Vauloup-Fellous, Christelle, Mariette, Xavier, Seror, Raphaèle
Publicado 2022

Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up

por Naovarat, Benjamin Sornrung, Salazar, Gloria, Ishimori, Mariko, Williams, Francis M, Reveille, John D
Publicado 2022

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician...

por Lawson-Tovey, Saskia, Machado, Pedro M, Strangfeld, Anja, Mateus, Elsa, Gossec, Laure, Carmona, Loreto, Raffeiner, Bernd, Bulina, Inita, Clemente, Daniel, Zepa, Julija, Rodrigues, Ana M., Mariette, Xavier, Hyrich, Kimme L
Publicado 2022

Reactive arthritis after SARS-CoV-2 infection

por Dombret, Sophia, Skapenko, Alla, Schulze-Koops, Hendrik
Publicado 2022

COVID-19-associated arthritis: an emerging new entity?

por Farisogullari, Bayram, Pinto, Ana S, Machado, Pedro M
Publicado 2022

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

por DiIorio, Michael, Kennedy, Kevin, Liew, Jean W, Putman, Michael S, Sirotich, Emily, Sattui, Sebastian E, Foster, Gary, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Moni, Tarin T, Thabane, Lehana, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Gore-Massy, Monique, Howard, Richard A, Kodhek, More A, Lalonde, Nadine, Tomasella, Laura-Ann, Wallace, John, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Eugenia Yupei, Conway, Richard, Duarte-García, Alí, Duff, Eimear, Gheita, Tamer A, Graef, Elizabeth R, Hsieh, Evelyn, El Kibbi, Lina, Liew, David FL, Lo, Chieh, Nudel, Michal, Singh, Aman Dev, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel F, Hausmann, Jonathan S, Simard, Julia F, Sparks, Jeffrey A
Publicado 2022

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

por Andreica, Ioana, Blazquez-Navarro, Arturo, Sokolar, Jan, Anft, Moritz, Kiltz, Uta, Pfaender, Stephanie, Vidal Blanco, Elena, Westhoff, Timm, Babel, Nina, Stervbo, Ulrik, Baraliakos, Xenofon
Publicado 2022

Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inbor...

por Calabrese, Cassandra, Kirchner, Elizabeth, Villa-Forte, Alexandra, Hajj-Ali, Rula A, Moss, Brandon P, Fernandez, James P, Calabrese, Leonard
Publicado 2022

Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis

por Stahl, David, tho Pesch, Carola, Brück, Carolin, Esser, Ruth L, Thiele, Jan, Di Cristanziano, Veronica, Kofler, David M
Publicado 2022

Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination

por Habermann, Elisa, Gieselmann, Lutz, Tober-Lau, Pinkus, Klotsche, Jens, Albach, Fredrik Nils, ten Hagen, Alexander, Zernicke, Jan, Ahmadov, Elvin, Arumahandi de Silva, Amanthi Nadira, Frommert, Leonie Maria, Kurth, Florian, Sander, Leif Erik, Burmester, Gerd R, Klein, Florian, Biesen, Robert
Publicado 2022

Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data

por Dey, Mrinalini, Bechman, Katie, Zhao, Sizheng, Fragoulis, George E, Smith, Catherine, Cope, Andrew, Nikiphorou, Elena, Hyrich, Kimme L, Galloway, James
Publicado 2022

Angioinvasive aspergillosis mimicking giant cell arteritis in an 81-year-old man with jaw pain and vision loss

por Guemara, Romain, Pieren, Amara, Brulhart, Laure
Publicado 2022